Clinical Trials Browser

OTHER_GOV × pembrolizumab × 90 days × Clear all

NCT05701527 2026-02-05

A Study of EBC-129 in Advanced Solid Tumours

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumours

NCT05036434 2026-01-23

ACCOMPLISH

Phase 2 Active not recruiting

Adrenocortical Carcinoma

NCT07349303 2026-01-21

NEOPRIME

Phase 2 Recruiting

Melanoma